Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02950987 · ClinicalTrials.gov registry record · NA

Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes

A NA study of Li-Fraumeni Syndrome, sponsored by Dana-Farber Cancer Institute.

Active
Registry status
NA
Development phase
150
Enrollment target
3
Study locations

NCT02950987 is a NA study of Li-Fraumeni Syndrome that is active but no longer recruiting, run by Dana-Farber Cancer Institute. The registered enrollment target is 150 participants, below the 2,051-participant average among 6 other Li-Fraumeni Syndrome trials with a reported enrollment target (93% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02950987, a NA study of Li-Fraumeni Syndrome, is active but no longer recruiting, sponsored by Dana-Farber Cancer Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
3
Study locations

Study Summary

This study is evaluating Whole Body MRI as a possible screening tool to diagnose cancer for people with LFS and other inherited cancer predisposition syndromes.

Conditions Studied

Li-Fraumeni Syndrome

Interventions

  • DEVICE Whole Body MRI

Study Locations (3)

Massachusetts

  • Dana Farber Cancer Institute - Boston

New York

  • Memorial Sloan-Kettering Cancer Center - New York

Pennsylvania

  • Children's Hospital of Philadelphia - Philadelphia

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2012-03
Est. Completion 2027-12
Phase NA

Sponsor

Dana-Farber Cancer Institute

781 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02950987

The ClinicalTrials.gov registry entry for NCT02950987 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,051-participant average among 6 other Li-Fraumeni Syndrome trials with a reported enrollment target (93% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Li-Fraumeni Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Whole Body MRI is the first listed.

NCT02950987 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Massachusetts, New York, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02950987 about?

NCT02950987 is a clinical study titled "Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes". This study is evaluating Whole Body MRI as a possible screening tool to diagnose cancer for people with LFS and other inherited cancer predisposition syndromes.

What is the current status of trial NCT02950987?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2012-03. Estimated completion is 2027-12.

What conditions does trial NCT02950987 study?

This clinical trial studies the following conditions: Li-Fraumeni Syndrome.

What interventions are being tested in trial NCT02950987?

The interventions under investigation include: Whole Body MRI (DEVICE).

Who is sponsoring clinical trial NCT02950987?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02950987 being conducted?

This trial has 3 study locations across Massachusetts, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Li-Fraumeni Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Li-Fraumeni Syndrome

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.